These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 20961218)

  • 1. The effect of adjuvant dimethylenastron, a mitotic Kinesin Eg5 inhibitor, in experimental glaucoma filtration surgery.
    Lüke J; Nassar K; Lüke M; Tura A; Merz H; Giannis A; Grisanti S
    Curr Eye Res; 2010 Dec; 35(12):1090-8. PubMed ID: 20961218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decorin modulates wound healing in experimental glaucoma filtration surgery: a pilot study.
    Grisanti S; Szurman P; Warga M; Kaczmarek R; Ziemssen F; Tatar O; Bartz-Schmidt KU
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):191-6. PubMed ID: 15623773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant decrease of ADP release rate underlies the potent activity of dimethylenastron to inhibit mitotic kinesin Eg5 and cancer cell proliferation.
    Sun L; Sun X; Xie S; Yu H; Zhong D
    Biochem Biophys Res Commun; 2014 May; 447(3):465-70. PubMed ID: 24732354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of novel EG5 inhibitors.
    Sarli V; Huemmer S; Sunder-Plassmann N; Mayer TU; Giannis A
    Chembiochem; 2005 Nov; 6(11):2005-13. PubMed ID: 16216042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Modulation of wound healing in filtration surgery for glaucoma].
    Jordan JF
    Ophthalmologe; 2003 Apr; 100(4):340-58; quiz 358-9. PubMed ID: 12682769
    [No Abstract]   [Full Text] [Related]  

  • 6. Dimethylenastron suppresses human pancreatic cancer cell migration and invasion in vitro via allosteric inhibition of mitotic kinesin Eg5.
    Sun XD; Shi XJ; Sun XO; Luo YG; Wu XJ; Yao CF; Yu HY; Li DW; Liu M; Zhou J
    Acta Pharmacol Sin; 2011 Dec; 32(12):1543-8. PubMed ID: 21986572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for inhibition of Eg5 by dihydropyrimidines: stereoselectivity of antimitotic inhibitors enastron, dimethylenastron and fluorastrol.
    Kaan HY; Ulaganathan V; Rath O; Prokopcová H; Dallinger D; Kappe CO; Kozielski F
    J Med Chem; 2010 Aug; 53(15):5676-83. PubMed ID: 20597485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled delivery of 5-chlorouracil using poly(ortho esters) in filtering surgery for glaucoma.
    Polak MB; Valamanesh F; Felt O; Torriglia A; Jeanny JC; Bourges JL; Rat P; Thomas-Doyle A; BenEzra D; Gurny R; Behar-Cohen F
    Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):2993-3003. PubMed ID: 18579761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of Rho-associated protein kinase inhibitor Y-27632 in glaucoma filtration surgery.
    Honjo M; Tanihara H; Kameda T; Kawaji T; Yoshimura N; Araie M
    Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5549-57. PubMed ID: 18055804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged antiscarring effects of ilomastat and MMC after experimental glaucoma filtration surgery.
    Wong TT; Mead AL; Khaw PT
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2018-22. PubMed ID: 15914618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validating the mitotic kinesin Eg5 as a therapeutic target in pancreatic cancer cells and tumor xenografts using a specific inhibitor.
    Liu M; Yu H; Huo L; Liu J; Li M; Zhou J
    Biochem Pharmacol; 2008 Jul; 76(2):169-78. PubMed ID: 18539263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of wound healing during and after glaucoma surgery.
    Georgoulas S; Dahlmann-Noor A; Brocchini S; Khaw PT
    Prog Brain Res; 2008; 173():237-54. PubMed ID: 18929113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glaucoma filtration surgery using amniotic membrane transplantation.
    Barton K; Budenz DL; Khaw PT; Tseng SC
    Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1762-8. PubMed ID: 11431440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-tocopherol derivatives and wound healing in an experimental model of filtering surgery.
    Larrosa JM; Polo V; Ramirez T; Pinilla I; Pablo LE; Honrubia FM
    Ophthalmic Surg Lasers; 2000; 31(2):131-5. PubMed ID: 10743924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New chemical tools for investigating human mitotic kinesin Eg5.
    Klein E; DeBonis S; Thiede B; Skoufias DA; Kozielski F; Lebeau L
    Bioorg Med Chem; 2007 Oct; 15(19):6474-88. PubMed ID: 17587586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of chronic hypotony after glaucoma filtration surgery.
    Liebmann JM; Sokol J; Ritch R
    J Glaucoma; 1996 Jun; 5(3):210-20. PubMed ID: 8795762
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of filtering surgery failure by subconjunctival injection of a novel peptide hydrogel into rabbit eyes.
    Liang L; Xu XD; Zhang XZ; Feng M; Peng C; Jiang FG
    Biomed Mater; 2010 Aug; 5(4):045008. PubMed ID: 20644242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic therapy for antifibrosis in a rabbit model of filtration surgery.
    Hill RA; Crean DH; Doiron DR; McDonald TJ; Liaw LH; Ghosheh F; Hamilton A; Berns MW
    Ophthalmic Surg Lasers; 1997 Jul; 28(7):574-81. PubMed ID: 9243661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of wound healing in glaucoma surgery.
    Van de Velde S; Van Bergen T; Vandewalle E; Moons L; Stalmans I
    Prog Brain Res; 2015; 221():319-40. PubMed ID: 26518085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of matrix metalloproteinases in wound healing after glaucoma filtration surgery in rabbits.
    Shima I; Katsuda S; Ueda Y; Takahashi N; Sasaki H
    Ophthalmic Res; 2007; 39(6):315-24. PubMed ID: 17957131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.